Loading…

Chinese firm Huating Biotechnology plans a cattle bone-processing plant in Kazakhstan's Turkestan region, with about $30 million in investment. The plant would make pharmaceutical peptone, aviation fuel oil and bone char, and the company plans to process animal blood into feed additives by 2027.
The project adds a new outlet for animal byproducts in Central Asia, but its scale is too small to move feed or commodity prices. It is a long-term development to watch.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.